Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,323
Sort by:
2017 Venezuela Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
January 2017
225 pages
2017 Vietnam Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
January 2017
225 pages
2017 Argentina Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Bahrain Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Bangladesh Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Brazil Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Chile Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 China Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Colombia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Croatia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Hong Kong Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
January 2017
1120 pages
2017 India Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Indonesia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Iran Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages